Filing Details

Accession Number:
0001453687-21-000164
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-06 16:25:46
Reporting Period:
2021-12-02
Accepted Time:
2021-12-06 16:25:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Selecta Biosciences Inc SELB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1884056 Kevin Tan 65 Grove Street
Watertown MA 02472
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-02 5,000 $3.03 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.02 to $3.0293. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.